Coherus BioSciences (CHRS) SEC Filings & 10K Form

$2.07
+0.03 (+1.47%)
(As of 04/29/2024 ET)

Recent Coherus BioSciences SEC Filings

DateFilerForm TypeView
04/15/2024
4:09 PM
Coherus BioSciences (Filer)
Form DEF 14A
04/15/2024
4:10 PM
Coherus BioSciences (Filer)
Form DEFA14A
04/15/2024
4:11 PM
Coherus BioSciences (Filer)
Form ARS
03/28/2024
3:04 PM
Coherus BioSciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/15/2024
4:13 PM
Coherus BioSciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/13/2024
3:16 PM
Coherus BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2024
5:22 AM
Coherus BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/15/2024
6:56 PM
Coherus BioSciences (Issuer)
Wahlstrom Mats (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
6:03 PM
Coherus BioSciences (Issuer)
Wahlstrom Mats (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
7:09 AM
Coherus BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/24/2024
8:46 AM
BlackRock Inc. (Filed by)
Coherus BioSciences (Subject)
Form SC 13G/A
01/23/2024
7:04 PM
Coherus BioSciences (Issuer)
McMichael Bryan J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
7:05 PM
Coherus BioSciences (Issuer)
Reider Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2024
7:07 PM
Coherus BioSciences (Issuer)
Lanfear Dennis M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2024
1:08 PM
Coherus BioSciences (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/22/2024
7:01 AM
Coherus BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2024
8:39 PM
Coherus BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2024
8:41 PM
Coherus BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2024
6:37 PM
Coherus BioSciences (Issuer)
McMichael Bryan J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
5:58 PM
Coherus BioSciences (Issuer)
Reider Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
6:04 PM
Coherus BioSciences (Issuer)
Lanfear Dennis M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
4:13 PM
Coherus BioSciences (Issuer)
Reider Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
4:14 PM
Coherus BioSciences (Issuer)
McMichael Bryan J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
3:42 PM
Coherus BioSciences (Issuer)
Stilwell McDavid (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2023
7:49 PM
Coherus BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/15/2023
3:47 PM
Coherus BioSciences (Issuer)
Reider Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2023
4:16 PM
Coherus BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/07/2023
1:45 PM
Coherus BioSciences (Subject)
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Form SC 13G/A
11/24/2023
3:04 PM
Coherus BioSciences (Issuer)
Lanfear Dennis M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
4:52 PM
Coherus BioSciences (Subject)
Lanfear Dennis M (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/13/2023
5:07 AM
Coherus BioSciences (Filer)
Form 8-K/A
11/06/2023
3:31 PM
Coherus BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2023
3:35 PM
Coherus BioSciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2023
5:07 AM
Coherus BioSciences (Filer)
Form 8-K/A
10/27/2023
3:19 PM
Coherus BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/06/2023
4:03 PM
Coherus BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/06/2023
1:34 PM
BlackRock Inc. (Filed by)
Coherus BioSciences (Subject)
Form SC 13G/A
09/12/2023
5:04 AM
Coherus BioSciences (Filer)
Form 424B5
09/12/2023
5:07 AM
Coherus BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/08/2023
8:12 AM
Coherus BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2023
3:05 PM
Coherus BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Biden out June 13; Kamala won’t replace him? (Ad)

On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.

See who it is HERE.
07/26/2023
11:15 PM
Coherus BioSciences (Filer)
Form EFFECT
07/24/2023
3:42 PM
Coherus BioSciences (Filer)
Form S-4/A
07/20/2023
4:01 PM
Coherus BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/20/2023
4:10 PM
Coherus BioSciences (Issuer)
Ryan Michael Lee (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/20/2023
4:11 PM
Coherus BioSciences (Issuer)
Ryan Michael Lee (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2023
4:03 PM
Coherus BioSciences (Filer)
Form S-4
Registration statement under Securities Act of 1933  
06/16/2023
4:11 PM
Coherus BioSciences (Filed by)
Surface Oncology, Inc. (Subject)
Form 425
06/16/2023
4:12 PM
Coherus BioSciences (Filed by)
Surface Oncology, Inc. (Subject)
Form 425
06/16/2023
4:14 PM
Coherus BioSciences (Filed by)
Surface Oncology, Inc. (Subject)
Form 425
06/16/2023
4:14 PM
Coherus BioSciences (Filed by)
Surface Oncology, Inc. (Subject)
Form 425
06/16/2023
4:16 PM
Coherus BioSciences (Filed by)
Surface Oncology, Inc. (Subject)
Form 425
06/16/2023
4:17 PM
Coherus BioSciences (Filed by)
Surface Oncology, Inc. (Subject)
Form 425
06/16/2023
7:08 AM
Coherus BioSciences (Subject)
Surface Oncology, Inc. (Filed by)
Form 425
06/16/2023
6:06 AM
Coherus BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/16/2023
6:09 AM
Coherus BioSciences (Filed by)
Surface Oncology, Inc. (Subject)
Form 425
06/15/2023
3:41 PM
Coherus BioSciences (Issuer)
McMichael Bryan J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2023
3:42 PM
Coherus BioSciences (Issuer)
Lanfear Dennis M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2023
3:39 PM
Coherus BioSciences (Issuer)
Reider Paul (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2023
3:40 PM
Coherus BioSciences (Issuer)
Stilwell McDavid (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2023
5:05 AM
Coherus BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/09/2023
4:07 PM
Coherus BioSciences (Issuer)
Newcomer Lee Nisley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2023
4:08 PM
Coherus BioSciences (Issuer)
STOLPER MARK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2023
4:09 PM
Coherus BioSciences (Issuer)
Wahlstrom Mats (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2023
11:57 AM
Coherus BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/19/2023
8:15 AM
CITADEL ADVISORS LLC (Filed by)
Coherus BioSciences (Subject)
Form SC 13G
05/16/2023
5:07 AM
Coherus BioSciences (Filer)
Form 424B5
05/15/2023
4:23 PM
Coherus BioSciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:CHRS) was last updated on 4/29/2024 by MarketBeat.com Staff

From Our Partners